Seres Therapeutics, Inc. (MCRB) Operating cash flow 2016–2025
Seres Therapeutics, Inc. (MCRB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$1.1MFY2025 · since FY2016: $43.9M → $1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1M | +100.8% |
| FY2024 | -$148.6M | -26.6% |
| FY2023 | -$117.4M | +48.7% |
| FY2022 | -$228.8M | -3521.3% |
| FY2021 | $6.7M | +107.1% |
| FY2020 | -$93.6M | -22.3% |
| FY2019 | -$76.5M | -21.7% |
| FY2018 | -$62.9M | +16.8% |
| FY2017 | -$75.5M | -272.0% |
| FY2016 | $43.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice